The Current State-of-the-Art Tissue Expression Analysis Platform for Detection & Quantification of Target & Biomarker mRNAs, Splice Variants and Mutations in Preclinical & Clinical Tissues

(FREE Continuing Education: P.A.C.E. CE | Florida CE)

Feb., 27, 2019 - 10:30 AM PST

Abstract:
Advanced Cell Diagnostics’ RNAscope products and assay services are utilized widely for tissue-based gene expression analysis in early target validation, preclinical animal efficacy and safety studies and in biomarker development. RNAscope is clinically validated and performs reliably on routine FFPE archival human tissues and clinical biopsies and any animal model tissues. Detection limits are at single molecule level, enabling quantitative, cell-specific expression analysis within tissue microenvironments. There are over 15,000 RNAscope probes in use and over 1,800 publications – more than 2-per-day. Continuing advances ... Learn More

Learning Objectives:

1. How RNAscope™ in situ hybridization is utilized for tissue-based, cell-specific expression analysis
2. How RNAscope™ is enabling gene therapy and cell therapy tissue biodistribution analysis

Speaker Biography:
Dr. Christopher Bunker is the Vice President of Business Development at Advanced Cell Diagnostics (ACD) in Newark, California. Dr. Bunker completed his doctoral research in Biological Chemistry at Harvard University and a Leukemia Society of America postdoctoral fellowship in molecular genetics at UCSF. He was a senior scientist in cancer functional genomics at Genome Therapeutics ... Learn More